Here are the most clinically significant terms and keywords extracted from the clinical guideline text, organized by category for clarity:

### **1. Protocol & Scope**  
- Protocol  
- Measurable standards  
- Professional judgement  
- BSUH NHS Trust  
- First year of life  

### **2. Responsibilities**  
- Midwives  
- Obstetricians  
- Accessing & following guidance  

### **3. Screening Overview**  
- Newborn Blood Spot Screening  
- Conditions screened:  
  - Phenylketonuria (PKU)  
  - Congenital hypothyroidism (CHT)  
  - MCADD (Medium-chain acyl-CoA dehydrogenase deficiency)  
  - Sickle Cell Disease (SCD)  
  - Cystic Fibrosis (CF) (if under 8 weeks)  
  - Maple Syrup Urine Disease (MSUD)  
  - Homocystinuria (HCU)  
  - Isovaleric Acidaemia (IVA)  
  - Glutaric Aciduria Type 1 (GA1)  

### **4. Consent & Declination**  
- Parental consent  
- Right to decline  
- Decline form  
- Potential complications of declining  
- Letter confirming decision  
- "NO RESEARCH CONTACT" (if parents refuse future research use)  

### **5. Sample Collection Procedures**  
- Day 5 of life (Day 5-8 in exceptional cases)  
- Heel prick  
- Automated incision device  
- Clean heel with plain water  
- Fill all 4 circles (single drops, no layering)  
- Expiry date check  
- NHS number on card  
- Barcoded label  
- Block capitals for additional info  
- Maternity code  

### **6. Documentation & Communication**  
- Record in maternity notes & PCHR (Personal Child Health Record)  
- Double-check before posting  
- Courier services (if disruptions)  
- Transport within 24 hours  
- First-class Royal Mail  
- Maximum 5 cards per envelope  
- Record sheets to central collection point  

### **7. Special Circumstances**  
- **Preterm babies (<32 weeks):**  
  - Routine sample on day 5  
  - Additional sample at 28 days or discharge  
- **NICU/SCBU admission:**  
  - Pre-transfusion spot on admission (1 spot)  
  - Routine screening delayed until 72h post-transfusion  
